Prakash Swayam, Agrawal Suraksha
Department of Medical Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow (UP) 226014 India.
Curr Drug Metab. 2016;17(9):862-876. doi: 10.2174/1389200217666160804150959.
Human genome sequencing highlights the involvement of genetic variation towards differential risk of human diseases, presence of different phenotypes, and response to pharmacological elements. This brings the field of personalized medicine to forefront in the era of modern health care. Numerous recent approaches have shown that how variation in the genome at single nucleotide level can be used in pharmacological research. The two broad aspects that deal with pharmacological research are pharmacogenetics and pharmacogenomics. This review encompasses how these variations have created the basis of pharmacogenetics and pharmacogenomics research and important milestones accomplished in these two fields in different diseases. It further discusses at length their importance in disease diagnosis, response of drugs, and various treatment modalities on the basis of genetic determinants.
人类基因组测序凸显了基因变异在人类疾病不同风险、不同表型的存在以及对药物成分反应方面的作用。这使得个性化医疗领域在现代医疗保健时代走到了前沿。最近的众多方法表明了单核苷酸水平的基因组变异如何应用于药理学研究。涉及药理学研究的两个主要方面是药物遗传学和药物基因组学。本综述涵盖了这些变异如何奠定了药物遗传学和药物基因组学研究的基础,以及在这两个领域针对不同疾病所取得的重要里程碑。它还详细讨论了它们在疾病诊断、药物反应以及基于基因决定因素的各种治疗方式中的重要性。